PYPD — PolyPid Ltd.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1611842 ·
Last close
$4.29
Market Cap
$82.26M
52W High
$5.73
52W Low
$3.65
ADV30
310,525
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -7,760,000 | -7,728,000 | 19,160,000 | 8,888,000 | 10,380,000 |
| Dec 2025 | 0 | — | -8,530,000 | -8,473,000 | 22,307,000 | 6,402,000 | 11,334,000 |
| Sep 2025 | 0 | — | -7,455,000 | -7,451,000 | 26,841,000 | 9,669,000 | 11,476,000 |
| Jun 2025 | 0 | — | -9,403,000 | -9,977,000 | 37,687,000 | 17,448,000 | 17,211,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-301,500,000
Inventory
$1,106,000
Receivables
—
ST Investments
$6,531,000
EBIT TTM
$-33,290,000
Pretax Income TTM
$-34,164,000
Interest Exp TTM
$1,839,000
Analysts
4
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -32,967,000 | -34,169,000 | 22,307,000 | 11,334,000 | — | -27,879,000 |
| Dec 2024 | 0 | -28,029,000 | -29,022,000 | 25,220,000 | 17,536,000 | — | -21,963,000 |
| Dec 2023 | 0 | -22,867,000 | -23,865,000 | 15,372,000 | 17,468,000 | — | -17,236,000 |
| Dec 2022 | 0 | -38,888,000 | -39,557,000 | 25,971,000 | 20,142,000 | — | -34,317,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.11
Max Pain — expiry 2026-09-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $5.00 · spot: $4.29 · call volume: 50 · put volume: 226
Expected Move to 2026-09-18:
±$1.65
(38.46%) —
implied range
$2.64 –
$5.94
· ATM straddle on $5.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SPAI | Safe Pro Group Inc. | $81.86M | $3.97 | — |
| OM | Outset Medical, Inc. | $84.72M | $4.57 | — |
| HYPR | Hyperfine, Inc. | $78.81M | $0.94 | — |
| NRXS | Neuraxis, INC | $77.98M | $6.25 | — |
| SKIN | SkinHealth Systems Inc. | $88.84M | $0.69 | — |
News headlines (Yahoo Finance, 1h cache)
PolyPid to Report Second Quarter 2026 Financial Results and Operational Highlights on August 12, 2026
2026-07-30 12:00 · Yahoo
PolyPid Announces FDA Acceptance of NDA with Priority Review for D-PLEX₁₀₀
2026-07-29 12:30 · Yahoo
Azurity Announces Plans to Commercialize D-PLEX100 in the U.S. and Canada through Exclusive Partnership with PolyPid
2026-07-21 13:15 · Yahoo
PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada
2026-07-21 11:30 · Yahoo
PolyPid Completes New Drug Application Submission to FDA for D-PLEX₁₀₀
2026-06-01 12:30 · Yahoo
PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference
2026-05-20 12:30 · Yahoo
PolyPid Ltd (PYPD) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
2026-05-13 23:01 · Yahoo
PolyPid Ltd. Q1 2026 Earnings Call Summary
2026-05-13 20:58 · Yahoo
PolyPid (PYPD) Q1 2026 Earnings Transcript
2026-05-13 19:01 · Yahoo
PolyPid Q1 Earnings Call Highlights
2026-05-13 18:09 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.